LONDON, Feb 8 (Reuters) - There is still some hope that the AstraZeneca and Oxford COVID-19 vaccine will prevent severe disease from the South African variant of coronavirus, according to the professor who found it had limited impact on mild disease.
South Africa on Sunday said it would put on hold the use of the shot in its vaccination programme, after data showed it gave minimal protection against mild-to-moderate infection caused by the country’s dominant coronavirus variant.
Shabir Madhi, who led the study in South Africa, said when looking at whether it could prevent severe disease, the AstraZeneca vaccine could be compared to the one made by Johnson & Johnson which has proved effective.
“There’s still some hope that the AstraZeneca vaccine might well perform as well as the Johnson and Johnson vaccine in a different age group demographic that I address of severe disease,” he told BBC radio. (Reporting by Kate Holton and Michael Holden; Editing by Guy Faulconbridge)
"severe" - Google News
February 08, 2021 at 03:38PM
https://ift.tt/3tEOEVl
Astra vaccine may stop severe disease from S.African variant, study leader says - Reuters
"severe" - Google News
https://ift.tt/2OrY17E
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Astra vaccine may stop severe disease from S.African variant, study leader says - Reuters"
Post a Comment